elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36236997-D1160004-F0A9-4859-A78A-91F569C0798D
Q36236997-D1160004-F0A9-4859-A78A-91F569C0798D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36236997-D1160004-F0A9-4859-A78A-91F569C0798D
Extracting the Benefit of Nexrutine® for Cancer Prevention.
P2860
Q36236997-D1160004-F0A9-4859-A78A-91F569C0798D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36236997-D1160004-F0A9-4859-A78A-91F569C0798D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
7e7ce95a03f13876b7da6b28a5bea91e1fa9a585
P2860
Long-term survival of participants in the prostate cancer prevention trial.